The Desmoid Tumor Research Foundation

August 2014

A systematic review of active treatment options in patients with desmoid tumours.

Author Information

A A Gupta,J Werier,M Ghert,R A Kandel,S Verma,T Corbett,X Yao

Cancer Care Ontario's Program in Evidence-Based Care, Department of Oncology, McMaster University, Hamilton, ON.,Department of Medical Oncology, The Ottawa Hospital Regional Cancer Centre, Ottawa, ON.,Department of Orthopaedic Surgery, The Ottawa Hospital Regional Cancer Centre, Ottawa, ON.,Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON.,Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON.,Division of Orthopaedic Surgery, Juravinski.,Division of Radiation Oncology, Juravinski Cancer Centre, Hamilton, ON.

Publication

Summary

We conducted a systematic review to determine the optimal treatment options in patients with desmoid tumours who have declined observational management. Significant toxicities were reported for all treatment modalities, including surgical morbidity, and rt- and chemotherapy-related toxicities. In patients who have declined observational management, the local control rate was higher with surgery plus rt than with surgery alone. However, the additional rt-related complications should be considered in treatment decision-making. Surgery, rt, and systemic therapy are all reasonable treatment options for patients with desmoid tumours.

View Abstract